OPN is increased in obesity, particularly within VAT, where it contributes to SASP‐related signalling, macrophage dysfunction, low‐grade systemic inflammation, insulin resistance and cardiometabolic risk. The gene discussed is SPP1; the disease is Insulin resistance.